Annual Net Income
-$51.85 M
+$10.78 M+17.21%
31 December 2023
Summary:
Checkpoint Therapeutics annual net profit is currently -$51.85 million, with the most recent change of +$10.78 million (+17.21%) on 31 December 2023. During the last 3 years, it has risen by +$4.82 million (+8.51%). CKPT annual net income is now -273.21% below its all-time high of -$13.89 million, reached on 31 December 2015.CKPT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$9.72 M
-$3.06 M-45.80%
30 September 2024
Summary:
Checkpoint Therapeutics quarterly net profit is currently -$9.72 million, with the most recent change of -$3.06 million (-45.80%) on 30 September 2024. Over the past year, it has increased by +$9.40 million (+49.16%). CKPT quarterly net income is now -196.40% below its all-time high of -$3.28 million, reached on 31 March 2020.CKPT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$46.47 M
-$4.00 M-9.42%
30 September 2024
Summary:
Checkpoint Therapeutics TTM net profit is currently -$46.47 million, with the most recent change of -$4.00 million (-9.42%) on 30 September 2024. Over the past year, it has increased by +$5.38 million (+10.37%). CKPT TTM net income is now -1139.48% below its all-time high of -$3.75 million, reached on 30 September 2015.CKPT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CKPT Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +49.2% | +10.4% |
| 3 y3 years | +8.5% | +67.3% | +18.0% |
| 5 y5 years | -109.8% | -10.2% | -88.0% |
CKPT Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -124.6% | +17.2% | -69.9% | +67.3% | -25.1% | +35.5% |
| 5 y | 5 years | -124.6% | +17.2% | -196.4% | +67.3% | -114.3% | +35.5% |
| alltime | all time | -273.2% | +17.2% | -196.4% | +67.3% | -1139.5% | +35.5% |
Checkpoint Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.72 M(+45.8%) | -$46.47 M(+9.4%) |
| June 2024 | - | -$6.67 M(-39.1%) | -$42.47 M(-18.8%) |
| Mar 2024 | - | -$10.95 M(-42.8%) | -$52.32 M(+0.9%) |
| Dec 2023 | -$51.85 M(-17.2%) | -$19.13 M(+234.2%) | -$51.85 M(-3.5%) |
| Sept 2023 | - | -$5.72 M(-65.4%) | -$53.74 M(-8.3%) |
| June 2023 | - | -$16.52 M(+57.7%) | -$58.63 M(+4.2%) |
| Mar 2023 | - | -$10.47 M(-50.2%) | -$56.25 M(-10.2%) |
| Dec 2022 | -$62.62 M(+10.5%) | -$21.02 M(+98.1%) | -$62.62 M(-12.2%) |
| Sept 2022 | - | -$10.61 M(-25.0%) | -$71.36 M(-0.9%) |
| June 2022 | - | -$14.14 M(-16.1%) | -$72.01 M(+7.5%) |
| Mar 2022 | - | -$16.85 M(-43.4%) | -$67.01 M(+18.3%) |
| Dec 2021 | -$56.67 M(+145.5%) | -$29.76 M(+164.1%) | -$56.67 M(+52.6%) |
| Sept 2021 | - | -$11.27 M(+23.2%) | -$37.14 M(+20.6%) |
| June 2021 | - | -$9.14 M(+40.6%) | -$30.80 M(+17.1%) |
| Mar 2021 | - | -$6.50 M(-36.4%) | -$26.30 M(+14.0%) |
| Dec 2020 | -$23.08 M | -$10.22 M(+107.4%) | -$23.08 M(+6.5%) |
| Sept 2020 | - | -$4.93 M(+6.1%) | -$21.68 M(-1.3%) |
| June 2020 | - | -$4.64 M(+41.6%) | -$21.96 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$3.28 M(-62.8%) | -$22.11 M(-10.6%) |
| Dec 2019 | -$24.71 M(-32.0%) | -$8.83 M(+69.5%) | -$24.71 M(-10.2%) |
| Sept 2019 | - | -$5.21 M(+8.6%) | -$27.51 M(-13.1%) |
| June 2019 | - | -$4.79 M(-18.6%) | -$31.64 M(-5.5%) |
| Mar 2019 | - | -$5.89 M(-49.3%) | -$33.49 M(-7.9%) |
| Dec 2018 | -$36.37 M(+60.4%) | -$11.62 M(+24.3%) | -$36.37 M(+18.6%) |
| Sept 2018 | - | -$9.34 M(+40.7%) | -$30.67 M(+12.5%) |
| June 2018 | - | -$6.64 M(-24.3%) | -$27.25 M(+0.7%) |
| Mar 2018 | - | -$8.77 M(+48.1%) | -$27.06 M(+19.3%) |
| Dec 2017 | -$22.68 M(+1.0%) | -$5.92 M(-0.2%) | -$22.68 M(-9.6%) |
| Sept 2017 | - | -$5.93 M(-8.1%) | -$25.08 M(+3.3%) |
| June 2017 | - | -$6.45 M(+47.1%) | -$24.28 M(+4.5%) |
| Mar 2017 | - | -$4.38 M(-47.3%) | -$23.24 M(+3.5%) |
| Dec 2016 | -$22.46 M(+61.7%) | -$8.32 M(+62.3%) | -$22.46 M(+1.2%) |
| Sept 2016 | - | -$5.13 M(-5.1%) | -$22.19 M(+6.6%) |
| June 2016 | - | -$5.41 M(+49.9%) | -$20.81 M(+35.1%) |
| Mar 2016 | - | -$3.60 M(-55.2%) | -$15.40 M(+30.6%) |
| Dec 2015 | -$13.89 M | -$8.05 M(+114.8%) | -$11.80 M(+214.8%) |
| Sept 2015 | - | -$3.75 M | -$3.75 M |
FAQ
- What is Checkpoint Therapeutics annual net profit?
- What is the all time high annual net income for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics quarterly net income year-on-year change?
- What is Checkpoint Therapeutics TTM net profit?
- What is the all time high TTM net income for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics TTM net income year-on-year change?
What is Checkpoint Therapeutics annual net profit?
The current annual net income of CKPT is -$51.85 M
What is the all time high annual net income for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high annual net profit is -$13.89 M
What is Checkpoint Therapeutics quarterly net profit?
The current quarterly net income of CKPT is -$9.72 M
What is the all time high quarterly net income for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high quarterly net profit is -$3.28 M
What is Checkpoint Therapeutics quarterly net income year-on-year change?
Over the past year, CKPT quarterly net profit has changed by +$9.40 M (+49.16%)
What is Checkpoint Therapeutics TTM net profit?
The current TTM net income of CKPT is -$46.47 M
What is the all time high TTM net income for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high TTM net profit is -$3.75 M
What is Checkpoint Therapeutics TTM net income year-on-year change?
Over the past year, CKPT TTM net profit has changed by +$5.38 M (+10.37%)